dorzolamide hydrochloride and timolol maleate ophthalmic solution- dorzolamide hydrochloride and timolol maleate solution/ drops
micro labs limited - dorzolamide hydrochloride (unii: qzo5366ew7) (dorzolamide - unii:9jdx055tw1), timolol maleate (unii: p8y54f701r) (timolol anhydrous - unii:5jky92s7br) - dorzolamide hydrochloride and timolol maleate ophthalmic solution is indicated for the reduction of elevated intraocular pressure (iop) in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to beta-blockers (failed to achieve target iop determined after multiple measurements over time). the iop-lowering of dorzolamide hydrochloride and timolol maleate ophthalmic solution administered twice a day was slightly less than that seen with the concomitant administration of 0.5% timolol administered twice a day and 2% dorzolamide administered three times a day [see clinical studies (14)]. dorzolamide hydrochloride and timolol maleate ophthalmic solution is contraindicated in patients with bronchial asthma, a history of bronchial asthma, or severe chronic obstructive pulmonary disease [see warnings and precautions (5.1)] . dorzolamide hydrochloride and timolol maleate ophthalmic solution is contraindi
cozdol 20/5 dorzolamide (as hydrochloride) 20 mg/ml and timolol (as maleate) 5 mg/ml eye drops solution bottle
arrow pharma pty ltd - dorzolamide hydrochloride,timolol maleate -
dorzolamide apotex dorzolamide (as hydrochloride) 20 mg/ml eye drops bottle
arrotex pharmaceuticals pty ltd - dorzolamide hydrochloride, quantity: 22.3 mg/ml (equivalent: dorzolamide, qty 20 mg/ml) - eye drops, solution - excipient ingredients: benzalkonium chloride; water for injections; sodium hydroxide; hyetellose; sodium citrate dihydrate; mannitol - dorzolamide eye drops are indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma.
vizo-pf dorzolatim dorzolamide (as hydrochloride) 20 mg/ml and timolol (as maleate) 5 mg/ml eye drop solution multi-dose bottle
aft pharmaceuticals pty ltd - dorzolamide hydrochloride, quantity: 22.26 mg/ml (equivalent: dorzolamide, qty 20 mg/ml); timolol maleate, quantity: 6.83 mg/ml (equivalent: timolol, qty 5 mg/ml) - eye drops, solution - excipient ingredients: sodium hydroxide; hyetellose; mannitol; water for injections; sodium citrate - vizo-pf dorzolatim is indicated in the treatment of elevated intraocular pressure (iop) in patients with ocular hypertension or open-angle glaucoma when concomitant therapy is appropriate.
dorzolamide hcl hydrochloride solution
actavis pharma, inc. - dorzolamide hydrochloride (unii: qzo5366ew7) (dorzolamide - unii:9jdx055tw1) - dorzolamide 20 mg in 1 ml
cosdor dorzolamide (as hydrochloride) 20 mg/ml and timolol (as maleate) 5 mg/ml eye drop bottle
viatris pty ltd - timolol maleate, quantity: 6.83 mg/ml (equivalent: timolol, qty 5 mg/ml); dorzolamide hydrochloride, quantity: 22.26 mg/ml (equivalent: dorzolamide, qty 20 mg/ml) - eye drops - excipient ingredients: mannitol; benzalkonium chloride; hyetellose; water for injections; sodium citrate dihydrate; sodium hydroxide - cosdor is indicated in the treatment of elevated intraocular pressure (iop) in patients with ocular hypertension or open-angle glaucoma when concomitant therapy is appropriate.
cosopt preservative-free dorzolamide (as hydrochloride) 20mg/ml and timolol (as maleate) 5mg/ml single dose eye drop ampoule
mundipharma pty ltd - timolol maleate, quantity: 6.83 mg/ml (equivalent: timolol, qty 5 mg/ml); dorzolamide hydrochloride, quantity: 22.26 mg/ml (equivalent: dorzolamide, qty 20 mg/ml) - eye drops, solution - excipient ingredients: mannitol; sodium hydroxide; water for injections; hyetellose; sodium citrate dihydrate - cosopt preservative free is indicated in the treatment of elevated intraocular pressure (iop) in patients with ocular hypertension or open-angle glaucoma when concominant therapy is appropriate.
trusopt
rafa laboratories ltd - dorzolamide as hydrochloride - ophthalmic solution - dorzolamide as hydrochloride 20 mg/ml - dorzolamide - dorzolamide - for the treatment of eleveated intraocular pressure in patients with ocular hypertension, open-angle glaucoma and in some patients secondary glaucoma.
dorzolamide hcl and timolol maleate- dorzolamide hydrochloride and timolol maleate solution
a-s medication solutions - dorzolamide hydrochloride (unii: qzo5366ew7) (dorzolamide - unii:9jdx055tw1), timolol maleate (unii: p8y54f701r) (timolol anhydrous - unii:5jky92s7br) - dorzolamide hydrochloride-timolol maleate ophthalmic solution, usp is indicated for the reduction of elevated intraocular pressure (iop) in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to beta-blockers (failed to achieve target iop determined after multiple measurements over time). the iop-lowering of dorzolamide hydrochloride-timolol maleate ophthalmic solution, usp administered twice a day was slightly less than that seen with the concomitant administration of 0.5% timolol administered twice a day and 2% dorzolamide administered three times a day [see clinical studies ( 14 )]. dorzolamide hydrochloride-timolol maleate ophthalmic solution is contraindicated in patients with bronchial asthma, a history of bronchial asthma, or severe chronic obstructive pulmonary disease [see warnings and precautions ( 5.1 )]. dorzolamide hydrochloride-timolol maleate ophthalmic solution is contraindicated in patients with sinus bradycardia, second or third degree atrioventricular
dorzolamide/timolol apotex 20/5 dorzolamide/timolol eye drops
arrotex pharmaceuticals pty ltd - timolol maleate, quantity: 6.8 mg/ml (equivalent: timolol, qty 5 mg); dorzolamide hydrochloride, quantity: 22.3 mg/ml (equivalent: dorzolamide, qty 20 mg) - eye drops, solution - excipient ingredients: mannitol; sodium citrate dihydrate; water for injections; benzalkonium chloride; sodium hydroxide; hyetellose - dorzolamide/timolol 20/5 eye drops are indicated in the treatment of elevated intraocular pressure (iop) in patients with ocular hypertension or open-angle glaucoma when concomitant therapy is appropriate.